Accreditation
The Icahn School of Medicine at Mount Sinai is accredited by the Middle States Commission on Higher Education (MSCHE), the regional institutional accrediting agency recognized by the United States Department of Education. MSCHE assures students and the public of the educational quaify for its accredited institutions of higher education.
Below is a list of accrediting agencies that accredit the school as well as specifc degree programs.
School Accreditation
Middle States Commission on Higher Education (MSCHE) | Accredited: Next Evaluation Team Site Visit Spring 2025
MSCHE Complaints
Degree Granting Authority
New York State Office of Higher Education
New York State ESSA-Funded Programs Complaint Procedures
MD Program
Liasion Committee on Medical Education (LCME) | Accredited: Next Survey Date 2027-28
LCME Complaints
Public Health Programs
Council on Education for Public Health (CEPH) | Accredited: Fully Reaccredited in December 2024 for a term until December 31,2031
CEPH Complaints
MS Genetic Counseling Program
Accreditation Council for Genetic Counseling (ACGC) | Accredited: Fully Reaccredited in December 2023 for 8 year term
ACGC Complaints
Program Retention and Graduate Rates
Information on MD Program and Graduate School Programs student retention and graduation rates are provided.
MD Program
Entering Cohort | % Graduated Entering Cohort | % Active
Fall 2016 | 97.7% Fall 2020* | 35.9%
Fall 2017 | 98.4% Fall 2021 | 99.1%
Fall 2018 | 98.4% Fall 2022 | 100.0%
Fall 2019 | 90.6% Fall 2023 | 99.1%
Fall 2020* | 57.8% Fall 2024 | 100.0%
* 57.8% graduated in four years, remaing 35.9% of cohort is active in a 5th year.
Graduate School Programs
By Degree Programs - Enter Fall 2020 through 2024 Cohorts | % Graduated or Active
MD-PhD Program | 2020 - 92.3%; 2021 - 100.0%; 2022 - 100.0%; 2023 - 90.0%; 2024 - 100.0%
PhD Biomedical Science/Neuroscience | 2020 - 92.5%; 2021 - 97.8%; 2022 - 96.9%; 2023 - 100.0%; 2024 - 100.0%
PhD Clinical Research | 2020 - 50.0%; 2021 - 77.8%; 2022 - 62.5%; 2023 - 66.7%; 2024 - 100.0%
MS Biomedical Science | 2020 - 83.0%; 2021 - 93.8%; 2022 - 87.0%; 2023 - 98.1%; 2024 - 100.0%
MS Biomedical Data Science | 2020 - 87.5%; 2021 - 100.0%; 2022 - 100.0%; 2023 - 66.7%; 2024 - 100.0%
MS Genetic Counseling | 2020 - 100.0%; 2021 - 100.0%; 2022 - 100.0%; 2023 - 100.0%; 2024 - 100.0%
MS Clinical Research | 2020 - 95.2%; 2021 - 88.9%; 2022 - 88.2%; 2023 - 84.6%; 2024 - 100.0%
Master of Public Health | 2020 - 79.5%; 2021 - 96.6%; 2022 - 92.3%; 2023 - 92.1%; 2024 - 100.0%
MS Epidemiology | 2020 - 100.0%; 2021 - 81.8%; 2022 - 66.7%; 2023 - 100.0%; 2024 - 100.0%
MS Biostatistics | 2020 - 80.0%; 2021 - 100.0%; 2022 - 100.0%; 2023 - 100.0%; 2024 - 100.0%
MS Health Care Delivery Leadership | 2020 - 87.5%; 2021 - 600.0%; 2022 - 100.0%; 2023 - 100.0%; 2024 - no cohort
Master of Health Administration | 2020 - 87.5%; 2021 - 92.3%; 2022 - 86.4%; 2023 - 68.8%; 2024 - 100.0%
Public Disclosures
Provided in the right menu are a series of public disclosure documents and reports, including annual security and safety reports, annual fire safety reports, financial disclosures, and credit hour assignment definitions.